Immunology

Immunology Today—April 8, 2026

This week’s Immunology update highlights regulatory and portfolio shifts, mid-…


Immunology

Immunology Today—April 1, 2026

This week’s Immunology update highlights regulatory progress, late-stage…


LucidQuest's AAD 2026 preview explores dermatology advances, AI applications and strategic implications for biopharma.

AAD 2026 Preview: Dermatology Trends, Clinical Advances and AI

AAD 2026 at a glance AAD 2026 will highlight emerging dermatology trends across…


Immunology

Immunology Today—March 18, 2026

This week’s Immunology update highlights regulatory progress, late-stage…


Immunology

Immunology Video Recap—March 11, 2026

This biweekly Immunology video recap highlights regulatory approvals,…


Immunology

Immunology Today—March 11, 2026

This week’s Immunology update highlights regulatory progress, positive…


AAAAI 2026_Preview_by_LucidQuest.pptx

AAAAI 2026 Preview: Key Allergy, Asthma and Immunology Highlights to Watch

AAAAI 2026 at a Glance Get ready for AAAAI 2026. LucidQuest’s preview brings…


Respiratory

Respiratory Today—February 27, 2026

This week’s Respiratory update highlights regulatory milestones, late-stage…


Immunology

Immunology Today—February 4, 2026

This weekly update in immunology covers significant developments in the field,…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen

Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen…


Immunology

Immunology Video Recap—January 28, 2026

This biweekly Immunology video recap highlights key regulatory actions,…


Immunology

Immunology Today—January 28, 2026

This weekly Immunology update covers late-stage clinical readouts, regulatory…


Privacy Preference Center